YF-VAX 1 dose vials
Ended Awarded
- Contract number
- SPE2DB25FH4ZG
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,113
Award facts
- Contract value 100% obligated
- $1,113.42 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $1,113.42 by the Defense Logistics Agency on April 24, 2025, for YF-VAX 1 Dose Vials. The contract carries an ultimate completion date of May 15, 2025, and will be performed at the awardee's Park Ridge facility. This award was made without a set-aside designation, allowing DMS Pharmaceutical Group to compete on the open market despite its small business status. The delivery order falls under the company's larger Indefinite Delivery Contract with DLA under the SPE2DB program, a $499.9 billion vehicle that enables the agency to procure pharmaceutical products and medical supplies for Department of Defense healthcare facilities worldwide.
DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, with a demonstrated portfolio of delivery orders covering an extensive range of medical products including vaccines, prescription medications, biologics, and medical consumables. The company's focus on providing direct pharmaceutical distribution to military health facilities positions it as a key partner for DLA's medical supply requirements. This particular delivery order for YF-VAX vaccine vials represents the type of routine pharmaceutical procurement that supports the Defense Logistics Agency's ongoing mission to supply vaccines and other critical medical products to Department of Defense healthcare sites globally.
Quick answers
Who was awarded contract SPE2DB25FH4ZG?
SPE2DB25FH4ZG was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on April 24, 2025.
How much is contract SPE2DB25FH4ZG worth?
The government has obligated $1,113 on SPE2DB25FH4ZG.
Is contract SPE2DB25FH4ZG an order under another contract?
Yes. SPE2DB25FH4ZG is a delivery order under SPE2DB22D9207, an indefinite delivery contract.
Was contract SPE2DB25FH4ZG competed?
The extent of competition for SPE2DB25FH4ZG was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award